Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Lupus inhibitors following bone marrow transplant
Edward W Greeno
, R. Haake
, P. McGlave
,
Daniel J Weisdorf
, C. Verfaillie
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lupus inhibitors following bone marrow transplant'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bone Marrow Transplantation
100%
Lupus Coagulation Inhibitor
100%
Hurler Syndrome
28%
University of Minnesota
14%
Cyclosporine
14%
Transplantation
14%
Immunoregulation
14%
Prospective Evaluation
14%
Pathologic
14%
Preparative Regimen
14%
Thrombocytopenia
14%
Viral Infection
14%
GVHD Prophylaxis
14%
Retrospective Analysis
14%
Busulfan
14%
Phenytoin
14%
High Incidence
14%
Non-associated
14%
Thrombotic Complications
14%
Disease States
14%
Coagulation Studies
14%
Cytoxan
14%
Seizure Prophylaxis
14%
In(III)
14%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Hurler Syndrome
100%
Busulfan
50%
Phenytoin
50%
Ciclosporin
50%
Virus Infection
50%
Cyclophosphamide
50%
Diseases
50%
Medicine and Dentistry
Bone Marrow Transplantation
100%
Lupus Erythematosus
100%
Hurler Syndrome
28%
Graft Versus Host Reaction
28%
Virus Infection
14%
Epileptic Seizure
14%
Immunoregulation
14%
Cyclophosphamide
14%
Cyclosporine
14%
Phenytoin
14%
Busulfan
14%
Diseases
14%
Immunology and Microbiology
Lupus Erythematosus
100%
Bone Marrow Transplantation
100%
Graft-Versus-Host Disease
28%
Viral Disease
14%
Ciclosporin
14%
Immunoregulation
14%
Cyclophosphamide
14%